STENO INTEN-CT Trial
Cross-source consensus on STENO INTEN-CT Trial from 1 sources and 5 claims.
1 sources · 5 claims
Uses
Other
Other
Other
Highlighted claims
- The trial is a pragmatic, open-label, event-driven randomised controlled trial across all five Danish regions. — Study protocol for the investigator-initiated Danish pragmatic randomised STENO INTEN-CT trial: does screening and intervention for subclinical coronary artery disease in type 2 diabetes reduce cardiovascular events?
- The STENO INTEN-CT trial tests whether CAC-based stratification with treatment intensification or de-intensification reduces cardiovascular events compared with standard care. — Study protocol for the investigator-initiated Danish pragmatic randomised STENO INTEN-CT trial: does screening and intervention for subclinical coronary artery disease in type 2 diabetes reduce cardiovascular events?
- The pragmatic design evaluates the strategy in real-world primary care rather than tightly controlled experimental conditions. — Study protocol for the investigator-initiated Danish pragmatic randomised STENO INTEN-CT trial: does screening and intervention for subclinical coronary artery disease in type 2 diabetes reduce cardiovascular events?
- Eligible participants have WHO-diagnosed T2DM, meet sex-specific age ranges, and have no documented cardiovascular disease history. — Study protocol for the investigator-initiated Danish pragmatic randomised STENO INTEN-CT trial: does screening and intervention for subclinical coronary artery disease in type 2 diabetes reduce cardiovascular events?
- Participants are recruited by linking personal identification numbers to national health registries and sending invitations through secure digital or physical mail. — Study protocol for the investigator-initiated Danish pragmatic randomised STENO INTEN-CT trial: does screening and intervention for subclinical coronary artery disease in type 2 diabetes reduce cardiovascular events?